Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$8.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| SSELL◷ |
| 64,399 |
| $53.98 |
| $3.5M |
| -100.0% |
| Open the original filing on SEC.gov |
| May 6 | RPRX | Royalty Pharma plc | AGRANT | 24,263 | — | — | +60.5% | Open the original filing on SEC.gov |
| Apr 28 | RPRX | Royalty Pharma plc | SSELL◷ | 1,875 | $49.78 | $93.3K | -4.5% | Open the original filing on SEC.gov |
| Apr 28 | RPRX | Royalty Pharma plc | SSELL◷ | 32,916 | $49.78 | $1.6M | -100.0% | Open the original filing on SEC.gov |
| Apr 1 | RPRX | Royalty Pharma plc | SSELL◷ | 32,916 | $48.33 | $1.6M | -50.0% | Open the original filing on SEC.gov |
| Apr 1 | RPRX | Royalty Pharma plc | SSELL◷ | 1,875 | $48.33 | $90.6K | -4.3% | Open the original filing on SEC.gov |
| Mar 23 | RPRX | Royalty Pharma plc | SSELL◷ | 1,875 | $45.53 | $85.4K | -4.1% | Open the original filing on SEC.gov |
| Mar 23 | RPRX | Royalty Pharma plc | SSELL◷ | 32,916 | $45.53 | $1.5M | -33.3% | Open the original filing on SEC.gov |